亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Angelicin Inhibits NSCLC Tumor Growth via the Inhibition of Cancer-Associated Fibroblasts

癌相关成纤维细胞 癌症研究 肿瘤微环境 癌症 医学 癌细胞 免疫疗法 药理学 内科学
作者
Binbin Ding,Hang Yin,Shuo Cao,Kai Cheng,Luna Ge
出处
期刊:Combinatorial Chemistry & High Throughput Screening [Bentham Science Publishers]
卷期号:29 (6): 1044-1058 被引量:3
标识
DOI:10.2174/0113862073366593250109093910
摘要

Objective: This study aimed to investigate the effect of angelicin on the NSCLC tumor growth. Background: Accumulating evidence shows that cancer-associated fibroblasts (CAFs) play an important role in tumor progression and metastasis, making CAFs an increasingly attractive target for therapeutic intervention. Targeted therapies against CAFs have been considered to have the potential to significantly improve cancer treatment outcomes, overcome resistance, and improve immune evasion. Angelicin (Ang), an active ingredient isolated from the Chinese herbal medicine Psoralea corylifolia Linn., has been reported to inhibit tumor progression. Due to its natural origin, angelicin has good clinical safety and low toxicity. Further clinical studies and exploration of its role as a CAF inhibitor in difficult-to-treat tumors like as NSCLC are expected to offer up a new channel for cancer treatment. Furthermore, angelicin's low cost and good biocompatibility make it have important application potential in cancer combination therapy, especially when used in combination with traditional therapies such as chemotherapy and immunotherapy, which may significantly improve treatment outcomes and reduce side effects. However, the mechanism of its anti-tumor effect remains poorly defined. The aim of this study was to investigate whether ANG modulates CAF activity to inhibit NSCLC progression. Methods: NIH3T3 cells are a mouse fibroblast cell line, and the use of NIH3T3 cells as a model for CAFs is mainly due to their natural fibroblast phenotype, ease of culture, good response to stimuli, and ability to simulate the functions of fibroblasts in the tumor microenvironment. NIH3T3 was treated with TGF-β (4ug/ml) and H2O2 (10μM). A conditioned medium was used to study the effect of Ang on tumor growth, invasion, and migration by regulating CAFs.Ang concentrations were set at 12.5, 25, and 50μM for cell cycle experiments and 0, 20, and 40μM for cell migration and invasion experiments. Subcutaneous tumors were established by mixing LLC and NIH3T3 cells to observe the effect of Ang on tumor progression and microenvironment. Fibroblast activity during Ang intervention was monitored by fluorescence-labeled FAPI-04 and 18F-labeled FAPI-04. The molecular pharmacological mechanism of Ang was investigated by RNA sequencing and network pharmacology. Results: The result showed that Ang significantly inhibited TGF-β and H2O2-induced NIH3T3 transformation, as evidenced by reduced expression of markers such as FAPα and α-SMA. Ang inhibited proliferation, invasion and migration of LLC cells induced by CAFs-conditioned medium. In vivo Experiments showed that Ang greatly inhibited tumor growth in Lewis’s lung cancer caused by CAFs. Molecular pharmacological analysis showed that Ang could modulate CAFs activity through multiple targets. These data indicate that Ang has a great potential to reduce CAF activity, interfere with the tumor microenvironment, and inhibit tumor growth. However, these findings still need to be further validated, especially considering the heterogeneity of CAFs, the differences between in vitro and in vivo models, and potential side effects. Conclusion: Ang reduced the growth, invasion, and migration of lung cancer by inactive CAFs. This provides a rationale for tumor microenvironment-based treatment of lung cancer and clinical translation of Ang. As a potential anti-cancer drug, Ang has shown significant effects in inhibiting cancer-related fibroblasts (CAFs) and disrupting the tumor microenvironment. However, there are still challenges in translating these findings into clinical treatments, such as heterogeneity of the tumor microenvironment, differences in patient responses, and side effects. Therefore, future research should focus on exploring personalized treatment strategies, evaluating the clinical safety and effectiveness of the drug, and delving deeper into the molecular mechanisms and target sites of Ang.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
科科科科发布了新的文献求助30
1秒前
大方碧完成签到,获得积分10
12秒前
哭泣的成协完成签到,获得积分10
17秒前
Akim的应助被小卡拉米采纳,获得10
22秒前
25秒前
我是老大的应助被科科科科采纳,获得10
30秒前
41秒前
小卡拉米发布了新的文献求助10
46秒前
大意的之柔完成签到,获得积分10
59秒前
CodeCraft的应助被欣喜寒烟采纳,获得10
1分钟前
小卡拉米完成签到,获得积分10
1分钟前
包容的初阳完成签到,获得积分10
1分钟前
深情安青的应助被荷兰香猪采纳,获得10
1分钟前
null的应助被科研通管家采纳,获得10
1分钟前
1分钟前
脑洞疼的应助被科研通管家采纳,获得10
1分钟前
null的应助被科研通管家采纳,获得10
1分钟前
AEGUO完成签到,获得积分10
1分钟前
1分钟前
荷兰香猪发布了新的文献求助10
1分钟前
年轻狗完成签到,获得积分10
1分钟前
完美世界的应助被whistle采纳,获得30
1分钟前
健忘香彤完成签到,获得积分10
1分钟前
2分钟前
欣喜寒烟发布了新的文献求助10
2分钟前
飞天大南瓜完成签到,获得积分10
2分钟前
2分钟前
粗暴的莹发布了新的文献求助10
2分钟前
2分钟前
科科科科发布了新的文献求助10
2分钟前
我是老大的应助被粗暴的莹采纳,获得10
2分钟前
2分钟前
害羞雪珊完成签到,获得积分10
2分钟前
自信醉香完成签到,获得积分10
2分钟前
whistle发布了新的文献求助30
2分钟前
2分钟前
Caden发布了新的文献求助10
3分钟前
荷兰香猪完成签到,获得积分10
3分钟前
Jasper的应助被whistle采纳,获得10
3分钟前
null的应助被科研通管家采纳,获得10
3分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8173069
求助须知:如何正确求助?哪些是违规求助? 9565519
关于积分的说明 21780424
捐赠科研通 7765088
什么是DOI,文献DOI怎么找? 3431536
关于科研通互助平台的介绍 2555638
邀请新用户注册赠送积分活动 2476668